Siemens Healthineers (Corindus): Telerobotic surgery pioneerSiemens Healthineers in 2019 spent $1.1 billion to acquire Corindus Vascular Robotics and its robot-assisted device that is FDA-cleared for coronary and peripheral vascular procedures.
Corindus’ CorPath GRX vascular robotic system boasts robotic-assisted control of coronary guide catheters, guidewires and rapid exchange catheters — with sub-millimeter measurement and 1 mm movement for proper stent positioning.
The system has enabled Corindus to be a pioneer in telerobotic surgery. The company was the subject of a documentary reviewing the power and potential of 5G technology. Called “The Speed of Thought,” it documented the first transcontinental interventional procedure performed using Corindus’ CorPath system. (Listen to an episode of DeviceTalks Weekly, in which Corindus COO Doug Teany discusses how 5G could enable more remote surgeries.)
In December 2020, Corindus launched a new set of automated robotic movements in its technIQ series for the CorPath GRX. The four newly launched automated movements give the technIQ series the ability to aid in complex tasks such as crossing lesions, navigating tortuosity and measuring the anatomy for appropriate device size selection.